eXoZymes Selected To Participate In Inaugural U.S. DOE Genesis Mission; Co. To Collaborate With Lawrence Berkeley National Laboratory On AI-Enabled Digital Twins For Cell-Free Biomanufacturing
eXoZymes Inc EXOZ
$4.65
▲ +1.09%
(+$0.05)
🎈 Low Float
🗓️ Earnings Next Week
Open
$4.89
Prev Close
$4.60
Day Range
$4.60 – $4.89
52W Range
$4.35 – $18.40
Market Cap
$43.16M
Beta
1.26
EPS (TTM)
$-1.15
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2024-11-13 |
| Shares Out. | 9,280,000 |
| Website | exozymes.com/ ↗ |
| Phone | 16264151488 |
| Employees | 32 |
| Net Income | -$2.4M |
| Free Cash Flow | -$7.1M |
| Total Assets | $4.0M |
| Total Liabilities | $2.5M |
| Equity | $1.5M |
About eXoZymes Inc
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods. The company believes its platform will enable scalable production of chemical molecules found in nature in a process that is alternative to and more environmentally friendly and sustainable than the typical methods used today, such as chemical synthesis, natural extraction, and synthetic biology.
eXoZymes Inc is a publicly traded company under the ticker symbol EXOZ on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.